Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference newsletter


  Cervical Cancer

  Free Subscription


26.10.2020

1 Acad Radiol
1 Adv Radiat Oncol
3 Am J Surg Pathol
2 Ann Surg Oncol
3 Annu Int Conf IEEE Eng Med Biol Soc
1 Arch Gynecol Obstet
1 Asia Pac J Clin Oncol
1 Biochem Biophys Res Commun
1 BJOG
1 BMC Public Health
1 BMJ Open
1 Br J Cancer
1 Br J Radiol
1 Cancer Biother Radiopharm
1 Cancer Control
3 Cancer Epidemiol Biomarkers Prev
5 Cancer Manag Res
1 Cancer Res Treat
1 Cancers (Basel)
1 Cells
1 Clocks Sleep
1 Colloids Surf B Biointerfaces
1 DNA Cell Biol
1 EBioMedicine
1 Environ Toxicol Pharmacol
2 Eur Rev Med Pharmacol Sci
1 Fertil Steril
1 Gynecol Obstet Invest
3 Gynecol Oncol
2 Gynecol Oncol Rep
1 Hereditas
1 Hum Cell
1 Indian J Cancer
1 Indian J Pathol Microbiol
1 Int Immunopharmacol
1 Int J Biol Sci
1 Int J Environ Res Public Health
1 Int J Gynecol Cancer
2 Int J Mol Sci
1 Int J Nanomedicine
1 Int J Radiat Oncol Biol Phys
1 Iran J Med Sci
1 J Cancer Educ
1 J Cell Biol
1 J Clin Oncol
4 J Gynecol Oncol
1 J Int Med Res
1 J Magn Reson Imaging
1 J Natl Cancer Inst
1 J Obstet Gynaecol Can
1 J Obstet Gynaecol Res
1 J Oncol Pharm Pract
1 J Recept Signal Transduct Res
1 J Transl Med
1 JAMA
1 Jpn J Clin Oncol
2 Jpn J Infect Dis
1 Med Sci Monit
1 Medicine (Baltimore)
1 mSphere
1 Pharmaceutics
1 PLoS One
1 Prev Med
1 Radiat Oncol
2 Radiother Oncol
1 Redox Biol
1 Reprod Sci
6 Rev Invest Clin
1 Trials
1 Vaccines (Basel)
1 Zhong Nan Da Xue Xue Bao Yi Xue Ban
1 Zhonghua Yi Xue Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acad Radiol

  1. WANG M, Perucho JAU, Chan Q, Sun J, et al
    Diffusion Kurtosis Imaging in the Assessment of Cervical Carcinoma.
    Acad Radiol. 2020;27:e94-e101.
    PubMed         Abstract available


    Adv Radiat Oncol

  2. SAYAN M, Mustafayev TZ, Atalar B, Gungor G, et al
    Magnetic Resonance-Guided Radiation Therapy to Boost Cervical Cancer When Brachytherapy Is Not Available: A Case Report.
    Adv Radiat Oncol. 2020;5:1066-1070.
    PubMed        


    Am J Surg Pathol

  3. DIBBERN ME, Bullock TN, Jenkins TM, Duska LR, et al
    Loss of MHC Class I Expression in HPV-associated Cervical and Vulvar Neoplasia: A Potential Mechanism of Resistance to Checkpoint Inhibition.
    Am J Surg Pathol. 2020;44:1184-1191.
    PubMed         Abstract available

  4. STOLNICU S, Segura S, Parra-Herran C, Horn LC, et al
    Invasive Stratified Mucin-producing Carcinoma (ISMC) of the Cervix: A Study on Morphologic Diversity.
    Am J Surg Pathol. 2020;44:873-880.
    PubMed         Abstract available

  5. ZARE SY, Aisagbonhi O, Hasteh F, Fadare O, et al
    Independent Validation of Tumor Budding Activity and Cell Nest Size as Determinants of Patient Outcome in Squamous Cell Carcinoma of the Uterine Cervix.
    Am J Surg Pathol. 2020 May 22. doi: 10.1097/PAS.0000000000001472.
    PubMed         Abstract available


    Ann Surg Oncol

  6. VIZZIELLI G, Tortorella L, Conte C, Chiantera V, et al
    Is a Vaginectomy Enough or is a Pelvic Exenteration Always Required for Surgical Treatment of Recurrent Cervical Cancer? A Propensity-Matched Study.
    Ann Surg Oncol. 2020 Oct 15. pii: 10.1245/s10434-020-09207.
    PubMed         Abstract available

  7. ZAPARDIEL I, Gracia M, Rychlik A, Querleu D, et al
    Adapting Radicality in Early Cervical Cancer When Quality of Life Becomes a Prominent Issue.
    Ann Surg Oncol. 2020 Oct 14. pii: 10.1245/s10434-020-09193.
    PubMed        


    Annu Int Conf IEEE Eng Med Biol Soc

  8. HU L, Horning MP, Banik D, Ajenifuja OK, et al
    Deep learning-based image evaluation for cervical precancer screening with a smartphone targeting low resource settings - Engineering approach.
    Annu Int Conf IEEE Eng Med Biol Soc. 2020;2020:1944-1949.
    PubMed         Abstract available

  9. ASIEDU MN, Skerrett E, Sapiro G, Ramanujam N, et al
    Combining multiple contrasts for improving machine learning-based classification of cervical cancers with a low-cost point-of-care Pocket colposcope.
    Annu Int Conf IEEE Eng Med Biol Soc. 2020;2020:1148-1151.
    PubMed         Abstract available

  10. ZHANG Z, He D, Song Y, Yan Z, et al
    Exploring the Inter-voxel Information in Pharmacokinetic Maps for Cervical Carcinoma Prediction.
    Annu Int Conf IEEE Eng Med Biol Soc. 2020;2020:1477-1480.
    PubMed         Abstract available


    Arch Gynecol Obstet

  11. KAVALLARIS A, Chalvatzas N, Gkoutzioulis A, Zygouris D, et al
    Laparoscopic nerve-sparing radical hysterectomy without uterine manipulator for cervical cancer stage IB: description of the technique, our experience and results after the era of LACC trial.
    Arch Gynecol Obstet. 2020 Oct 17. pii: 10.1007/s00404-020-05835.
    PubMed         Abstract available


    Asia Pac J Clin Oncol

  12. ZHANG D, Zhang Y, Sun X
    LINC01133 promotes the progression of cervical cancer via regulating miR-30a-5p/FOXD1.
    Asia Pac J Clin Oncol. 2020 Oct 20. doi: 10.1111/ajco.13451.
    PubMed         Abstract available


    Biochem Biophys Res Commun

  13. KUBOTA S, Tanaka M, Endo H, Ito Y, et al
    Dedifferentiation of neuroendocrine carcinoma of the uterine cervix in hypoxia.
    Biochem Biophys Res Commun. 2020;524:398-404.
    PubMed         Abstract available


    BJOG

  14. ROSSI EC
    An evolution in sentinel node mapping for cervical cancer.
    BJOG. 2020 Oct 16. doi: 10.1111/1471-0528.16568.
    PubMed         Abstract available


    BMC Public Health

  15. AMIN R, Kolahi AA, Jahanmehr N, Abadi AR, et al
    Disparities in cervical cancer screening participation in Iran: a cross-sectional analysis of the 2016 nationwide STEPS survey.
    BMC Public Health. 2020;20:1594.
    PubMed         Abstract available


    BMJ Open

  16. DEREJE N, Gebremariam A, Addissie A, Worku A, et al
    Factors associated with advanced stage at diagnosis of cervical cancer in Addis Ababa, Ethiopia: a population-based study.
    BMJ Open. 2020;10:e040645.
    PubMed         Abstract available


    Br J Cancer

  17. ZHANG Y, Yu M, Jing Y, Cheng J, et al
    Baseline immunity and impact of chemotherapy on immune microenvironment in cervical cancer.
    Br J Cancer. 2020 Oct 22. pii: 10.1038/s41416-020-01123.
    PubMed         Abstract available


    Br J Radiol

  18. SONG Q, Yu Y, Zhang X, Zhu Y, et al
    Value of MRI and diffusion weighted imaging in diagnosing normal-sized pelvic lymph nodes metastases in patients with cervical cancer.
    Br J Radiol. 2020 Oct 23:20200203. doi: 10.1259/bjr.20200203.
    PubMed         Abstract available


    Cancer Biother Radiopharm

  19. LIN L, Li N, Hu X, Sun J, et al
    Identification of circ_0085616 as an Upregulated and Oncogenic Circular RNA in Cervical Cancer Via the miR-503-5p-Mediated ATXN7L3 Activation.
    Cancer Biother Radiopharm. 2020 Oct 21. doi: 10.1089/cbr.2020.3865.
    PubMed         Abstract available


    Cancer Control

  20. KAWASHITA S, Matsuda K, Kondo H, Kitajima Y, et al
    Significance of p53-Binding Protein 1 Nuclear Foci in Cervical Squamous Intraepithelial Lesions: Association With High-Risk Human Papillomavirus Infection and P16(INK4a) Expression.
    Cancer Control. 2020;27:1073274819901170.
    PubMed         Abstract available


    Cancer Epidemiol Biomarkers Prev

  21. SHEN Q, Lu D, Andrae B, Schelin MEC, et al
    Risk of Injuries around Diagnosis of Cervical Cancer and Its Precursor Lesions: A Nationwide Cohort Study in Sweden.
    Cancer Epidemiol Biomarkers Prev. 2020 Oct 21. pii: 1055-9965.EPI-20-0673.
    PubMed         Abstract available

  22. GOTTSCHLICH A, van Niekerk D, Smith LW, Gondara L, et al
    Assessing 10-year safety of a single negative HPV test for cervical cancer screening: Evidence from FOCAL-DECADE cohort.
    Cancer Epidemiol Biomarkers Prev. 2020 Oct 20. pii: 1055-9965.EPI-20-1177.
    PubMed         Abstract available

  23. MIX JM, Van Dyne EA, Saraiya M, Hallowell BD, et al
    Assessing Impact of HPV Vaccination on Cervical Cancer Incidence in Women 15-29 years in the United States, 1999-2017: An Ecologic Study.
    Cancer Epidemiol Biomarkers Prev. 2020 Oct 20. pii: 1055-9965.EPI-20-0846.
    PubMed         Abstract available


    Cancer Manag Res

  24. MA J, Wang W, Shen J, Hou X, et al
    Radiotherapy for Cervical Cancer in Patients with Systemic Lupus Erythematosus.
    Cancer Manag Res. 2020;12:8675-8683.
    PubMed         Abstract available

  25. CHEN L, Zhang X, Wang S, Lin X, et al
    Circ_0084927 Facilitates Cervical Cancer Development via Sponging miR-142-3p and Upregulating ARL2.
    Cancer Manag Res. 2020;12:9271-9283.
    PubMed         Abstract available

  26. WANG R, Liu L, Jiao J, Gao D, et al
    Knockdown of MIR4435-2HG Suppresses the Proliferation, Migration and Invasion of Cervical Cancer Cells via Regulating the miR-128-3p/MSI2 Axis in vitro.
    Cancer Manag Res. 2020;12:8745-8756.
    PubMed         Abstract available

  27. SHI P, Zhang X, Lou C, Xue Y, et al
    Hsa_circ_0084927 Regulates Cervical Cancer Advancement via Regulation of the miR-634/TPD52 Axis.
    Cancer Manag Res. 2020;12:9435-9448.
    PubMed         Abstract available

  28. SONG F, Du H, Xiao A, Wang C, et al
    Evaluating the Performance of p16(INK4a) Immunocytochemistry in Cervical Cancer Screening.
    Cancer Manag Res. 2020;12:9067-9075.
    PubMed         Abstract available


    Cancer Res Treat

  29. LI LY, Wen LY, Park SH, Nam EJ, et al
    Impact of the Learning Curve on the Survival of Abdominal or Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer.
    Cancer Res Treat. 2020 Oct 12. pii: crt.2020.063. doi: 10.4143/crt.2020.
    PubMed         Abstract available


    Cancers (Basel)

  30. PUROHIT S, Zhi W, Ferris DG, Alverez M, et al
    Senescence-Associated Secretory Phenotype Determines Survival and Therapeutic Response in Cervical Cancer.
    Cancers (Basel). 2020;12.
    PubMed         Abstract available


    Cells

  31. GUTIERREZ-HOYA A, Soto-Cruz I
    Role of the JAK/STAT Pathway in Cervical Cancer: Its Relationship with HPV E6/E7 Oncoproteins.
    Cells. 2020;9.
    PubMed         Abstract available


    Clocks Sleep

  32. SATO F, Bhawal UK, Sugiyama N, Osaki S, et al
    Potential Role of DEC1 in Cervical Cancer Cells Involving Overexpression and Apoptosis.
    Clocks Sleep. 2020;2:26-38.
    PubMed         Abstract available


    Colloids Surf B Biointerfaces

  33. S R, M P
    Multi-functional FITC-silica@gold nanoparticles conjugated with guar gum succinate, folic acid and doxorubicin for CT/fluorescence dual imaging and combined chemo/PTT of cancer.
    Colloids Surf B Biointerfaces. 2020;186:110701.
    PubMed         Abstract available


    DNA Cell Biol

  34. WANG Q, Zhang Q, Huang Y, Zhang J, et al
    m(1)A Regulator TRMT10C Predicts Poorer Survival and Contributes to Malignant Behavior in Gynecological Cancers.
    DNA Cell Biol. 2020;39:1767-1778.
    PubMed         Abstract available


    EBioMedicine

  35. SCHOLL SM, Beal J, de Koning L, Girard E, et al
    Genetic markers and phosphoprotein forms of beta-catenin pbeta-Cat552 and pbeta-Cat675 are prognostic biomarkers of cervical cancer.
    EBioMedicine. 2020;61:103049.
    PubMed         Abstract available


    Environ Toxicol Pharmacol

  36. TAN Y, Wang H, Zhang C
    MicroRNA-381 targets G protein-Coupled receptor 34 (GPR34) to regulate the growth, migration and invasion of human cervical cancer cells.
    Environ Toxicol Pharmacol. 2020 Oct 18:103514. doi: 10.1016/j.etap.2020.103514.
    PubMed         Abstract available


    Eur Rev Med Pharmacol Sci

  37. TIAN Y, Wang YR, Jia SH
    Knockdown of long noncoding RNA DLX6-AS1 inhibits cell proliferation and invasion of cervical cancer cells by downregulating FUS.
    Eur Rev Med Pharmacol Sci. 2020;24:9771.
    PubMed         Abstract available

  38. YANG TJ, Wang L, Zhang Y, Zheng JD, et al
    LncRNA UCA1 regulates cervical cancer survival and EMT occurrence by targeting miR-155.
    Eur Rev Med Pharmacol Sci. 2020;24:9869-9879.
    PubMed         Abstract available


    Fertil Steril

  39. DE VINCENZO R, Ricci C, Fanfani F, Gui B, et al
    Neoadjuvant chemotherapy followed by conization in stage IB2-IIA1 cervical cancer larger than 2 cm: a pilot study.
    Fertil Steril. 2020 Oct 19. pii: S0015-0282(20)30630.
    PubMed         Abstract available


    Gynecol Obstet Invest

  40. OOI S, Liao Y, Liu P, Xu G, et al
    Identification of Long Noncoding RNA Expression Profiles in HPV-Negative Cervical Cancer.
    Gynecol Obstet Invest. 2020 Oct 14:1-11. doi: 10.1159/000510030.
    PubMed         Abstract available


    Gynecol Oncol

  41. HAN X, Liu S, Yang G, Hosseinifard H, et al
    Prognostic value of systemic hemato-immunological indices in uterine cervical cancer: A systemic review, meta-analysis, and meta-regression of observational studies.
    Gynecol Oncol. 2020 Oct 19. pii: S0090-8258(20)34019.
    PubMed         Abstract available

  42. BREWSTER WR
    Insurance and adherence to guideline concordant cervical cancer therapy do not reduce mortality?
    Gynecol Oncol. 2020;159:297-298.
    PubMed        

  43. HUNG P, Zahnd WE, Brandt HM, Adams SA, et al
    Cervical cancer treatment initiation and survival: The role of residential proximity to cancer care.
    Gynecol Oncol. 2020 Oct 17. pii: S0090-8258(20)34014.
    PubMed         Abstract available


    Gynecol Oncol Rep

  44. VINAY KUMAR R
    Conventional radiotherapy planning of cervical cancer in resource-constrained set-up: Utilizing soldering lead wire to delineate radiotherapy portal.
    Gynecol Oncol Rep. 2020;34:100650.
    PubMed         Abstract available

  45. WELP A, Fields EC, Randall L, Brown FK, et al
    Acute extraperitoneal spontaneous bladder rupture in cervical cancer patient undergoing chemoradiation: A case report and review of the literature.
    Gynecol Oncol Rep. 2020;34:100656.
    PubMed         Abstract available


    Hereditas

  46. WU X, Zhong Y, Chen Q, Zhang X, et al
    Enhancer of mRNA Decapping protein 4 (EDC4) interacts with replication protein a (RPA) and contributes to Cisplatin resistance in cervical Cancer by alleviating DNA damage.
    Hereditas. 2020;157:41.
    PubMed         Abstract available


    Hum Cell

  47. LI F, Zhu W, Wang Z
    Long noncoding RNA LINC00460 promotes the progression of cervical cancer via regulation of the miR-361-3p/Gli1 axis.
    Hum Cell. 2020 Oct 16. pii: 10.1007/s13577-020-00447.
    PubMed         Abstract available


    Indian J Cancer

  48. SALUNKHE R, Chopra S, Kulkarni S, Shetty N, et al
    Outcomes of locally advanced cervical cancer presenting with obstructive uropathy: An institutional audit.
    Indian J Cancer. 2020;57:416-422.
    PubMed         Abstract available


    Indian J Pathol Microbiol

  49. HU J, Lu Y, Tang N, Li L, et al
    Expression of alpha-methylacyl-CoA racemase in vaginal gastric-type adenocarcinoma and uterine clear cell carcinoma.
    Indian J Pathol Microbiol. 2020;63:49-52.
    PubMed         Abstract available


    Int Immunopharmacol

  50. DATTA A, Tuz Zahora F, Abdul Aziz M, Sarowar Uddin M, et al
    Association study of IL10 gene polymorphisms (rs1800872 and rs1800896) with cervical cancer in the Bangladeshi women.
    Int Immunopharmacol. 2020;89.
    PubMed         Abstract available


    Int J Biol Sci

  51. XU L, Wang J, Yuan X, Yang S, et al
    IU1 suppresses proliferation of cervical cancer cells through MDM2 degradation.
    Int J Biol Sci. 2020;16:2951-2963.
    PubMed         Abstract available


    Int J Environ Res Public Health

  52. LE XTT, Nguyen PTN, Do TTT, Nguyen TH, et al
    Intention to Pay for HPV Vaccination among Women of Childbearing Age in Vietnam.
    Int J Environ Res Public Health. 2020;17.
    PubMed         Abstract available


    Int J Gynecol Cancer

  53. LIN F, Zheng R, Yu C, Su Y, et al
    Predictive role of serum cholesterol and triglycerides in cervical cancer survival.
    Int J Gynecol Cancer. 2020 Oct 13. pii: ijgc-2020-001333.
    PubMed         Abstract available


    Int J Mol Sci

  54. CHUNG SF, Kim CF, Chow HY, Chong HC, et al
    Recombinant Bacillus caldovelox Arginase Mutant (BCA-M) Induces Apoptosis, Autophagy, Cell Cycle Arrest and Growth Inhibition in Human Cervical Cancer Cells.
    Int J Mol Sci. 2020;21.
    PubMed         Abstract available

  55. RHO SB, Lee SH, Byun HJ, Kim BR, et al
    IRF-1 Inhibits Angiogenic Activity of HPV16 E6 Oncoprotein in Cervical Cancer.
    Int J Mol Sci. 2020;21.
    PubMed         Abstract available


    Int J Nanomedicine

  56. PENG J, Zhao J, Zhao Y, Wu P, et al
    HeLa Cell-Derived Paclitaxel-Loaded Microparticles Efficiently Inhibit the Growth of Cervical Carcinoma.
    Int J Nanomedicine. 2020;15:6409-6420.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  57. ARYA R, Golden DW
    A Curious Case of Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2020;108:846-847.
    PubMed        


    Iran J Med Sci

  58. SARGAZI S, Moudi M, Kooshkaki O, Mirinejad S, et al
    Hydro-alcoholic Extract of Achillea Wilhelmsii C. Koch Reduces the Expression of Cell Death-Associated Genes while Inducing DNA Damage in HeLa Cervical Cancer Cells.
    Iran J Med Sci. 2020;45:359-367.
    PubMed         Abstract available


    J Cancer Educ

  59. JOSHI SV, Chaudhari HR, Chaudhari NA
    Effect of Education on Awareness, Knowledge, and Willingness to Be Vaccinated in Females of Western India.
    J Cancer Educ. 2020;35:61-68.
    PubMed         Abstract available


    J Cell Biol

  60. HANEKE K, Schott J, Lindner D, Hollensen AK, et al
    CDK1 couples proliferation with protein synthesis.
    J Cell Biol. 2020;219.
    PubMed         Abstract available


    J Clin Oncol

  61. LAN C, Shen J, Wang Y, Li J, et al
    Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial.
    J Clin Oncol. 2020 Oct 14:JCO2001920. doi: 10.1200/JCO.20.01920.
    PubMed         Abstract available


    J Gynecol Oncol

  62. ZHUANG S, Yu X, Lu M, Li Y, et al
    High mobility group box 3 promotes cervical cancer proliferation by regulating Wnt/beta-catenin pathway.
    J Gynecol Oncol. 2020;31:e91.
    PubMed         Abstract available

  63. CHANG JS, Kim N, Kim JY, Do SI, et al
    Kallikrein 5 overexpression is associated with poor prognosis in uterine cervical cancer.
    J Gynecol Oncol. 2020;31:e78.
    PubMed         Abstract available

  64. PAN X, Yang W, Wen Z, Li F, et al
    Does adenocarcinoma have a worse prognosis than squamous cell carcinoma in patients with cervical cancer? A real-world study with a propensity score matching analysis.
    J Gynecol Oncol. 2020;31:e80.
    PubMed         Abstract available

  65. DELARA R, Yang J, Buckner-Petty S, Magtibay P, et al
    Surgical or imaging lymph node assessment in locally advanced cervical cancer: a systematic review and meta-analysis.
    J Gynecol Oncol. 2020;31:e79.
    PubMed         Abstract available


    J Int Med Res

  66. YE G, Wang L, Yang K, Wang C, et al
    Fucoxanthin may inhibit cervical cancer cell proliferation via downregulation of HIST1H3D.
    J Int Med Res. 2020;48:300060520964011.
    PubMed         Abstract available


    J Magn Reson Imaging

  67. LI X, Wu S, Li D, Yu T, et al
    Intravoxel Incoherent Motion Combined With Dynamic Contrast-Enhanced Perfusion MRI of Early Cervical Carcinoma: Correlations Between Multimodal Parameters and HIF-1alpha Expression.
    J Magn Reson Imaging. 2019 Jan 16. doi: 10.1002/jmri.26604.
    PubMed         Abstract available


    J Natl Cancer Inst

  68. CLARK CR, Haas JS, Lemon SC, Freund KM, et al
    RE: How the Coronavirus Disease-2019 May Improve Care: Rethinking Cervical Cancer Prevention.
    J Natl Cancer Inst. 2020 Oct 15. pii: 5924373. doi: 10.1093.
    PubMed        


    J Obstet Gynaecol Can

  69. STEBEN M, Norris T, Rosberger Z
    COVID-19 Won't Be the Last (Or Worst) Pandemic: It's Time to Build Resilience Into Our Cervical Cancer Elimination Goals.
    J Obstet Gynaecol Can. 2020;42:1195-1196.
    PubMed        


    J Obstet Gynaecol Res

  70. UEDA K, Yanaihara N, Iida Y, Kobayashi R, et al
    Analysis of risk factors for patients with early-stage cervical cancer: A study of 374 patients.
    J Obstet Gynaecol Res. 2020 Oct 19. doi: 10.1111/jog.14510.
    PubMed         Abstract available


    J Oncol Pharm Pract

  71. DIMOND C, Negroiu A, M Hughes D, Patel J, et al
    Fatal hepatitis B reactivation in a patient receiving chemoradiation for cervical cancer.
    J Oncol Pharm Pract. 2020 Oct 14:1078155220964256. doi: 10.1177/1078155220964256
    PubMed         Abstract available


    J Recept Signal Transduct Res

  72. ZHANG L, Wei Z, Wang Y, Xu F, et al
    Long noncoding RNA ROR1-AS1 enhances STC2-mediated cell growth and autophagy in cervical cancer through miR-670-3p.
    J Recept Signal Transduct Res. 2020.
    PubMed         Abstract available


    J Transl Med

  73. NI HH, Zhang L, Huang H, Dai SQ, et al
    Connecting METTL3 and intratumoural CD33(+) MDSCs in predicting clinical outcome in cervical cancer.
    J Transl Med. 2020;18:393.
    PubMed         Abstract available


    JAMA

  74. LEMP JM, De Neve JW, Bussmann H, Chen S, et al
    Lifetime Prevalence of Cervical Cancer Screening in 55 Low- and Middle-Income Countries.
    JAMA. 2020;324:1532-1542.
    PubMed         Abstract available


    Jpn J Clin Oncol

  75. SOMEYA M, Tsuchiya T, Fukushima Y, Hasegawa T, et al
    Association between cancer immunity and treatment results in uterine cervical cancer patients treated with radiotherapy.
    Jpn J Clin Oncol. 2020;50:1290-1297.
    PubMed         Abstract available


    Jpn J Infect Dis

  76. LI L, Chen Y, Chen J, Su Q, et al
    Prevalence and Genotype Distribution of High-Risk Human Papillomavirus among Chinese Women in Sichuan Province.
    Jpn J Infect Dis. 2020;73:96-101.
    PubMed         Abstract available

  77. COLIN-FERREYRA MDC, Dominguez-Garcia MV, Mendieta-Zeron H, Camarillo-Romero MDS, et al
    Genotyping of Human Papillomavirus in Cervical Squamous Intraepithelial Lesions in Mexican Women.
    Jpn J Infect Dis. 2020;73:157-160.
    PubMed         Abstract available


    Med Sci Monit

  78. YIN L, Chen G
    Verteporfin Promotes the Apoptosis and Inhibits the Proliferation, Migration, and Invasion of Cervical Cancer Cells by Downregulating SULT2B1 Expression.
    Med Sci Monit. 2020;26:e926780.
    PubMed         Abstract available


    Medicine (Baltimore)

  79. CHEN Y, Fang C, Zhang K, Deng Q, et al
    Distribution patterns of lymph node metastasis in early stage invasive cervical cancer.
    Medicine (Baltimore). 2020;99:e22285.
    PubMed         Abstract available


    mSphere

  80. JAMES CD, Fontan CT, Otoa R, Das D, et al
    Human Papillomavirus 16 E6 and E7 Synergistically Repress Innate Immune Gene Transcription.
    mSphere. 2020;5.
    PubMed         Abstract available


    Pharmaceutics

  81. NOH JJ, Kim MS, Cho YJ, Jeong SY, et al
    Anti-Cancer Activity of As4O6 and its Efficacy in a Series of Patient-Derived Xenografts for Human Cervical Cancer.
    Pharmaceutics. 2020;12.
    PubMed         Abstract available


    PLoS One

  82. MOODLEY J, Constant D, Mwaka AD, Scott SE, et al
    Mapping awareness of breast and cervical cancer risk factors, symptoms and lay beliefs in Uganda and South Africa.
    PLoS One. 2020;15:e0240788.
    PubMed         Abstract available


    Prev Med

  83. BROTHERTON JML, Wheeler C, Clifford G, Elfstrom M, et al
    Surveillance systems for monitoring cervical cancer elimination efforts: Focus on HPV infection, cervical dysplasia, cervical screening and treatment.
    Prev Med. 2020 Oct 16:106293. doi: 10.1016/j.ypmed.2020.106293.
    PubMed         Abstract available


    Radiat Oncol

  84. PANDA S, Swamidas J, Chopra S, Mangaj A, et al
    Treatment planning comparison of volumetric modulated arc therapy employing a dual-layer stacked multi-leaf collimator and helical tomotherapy for cervix uteri.
    Radiat Oncol. 2020;15:22.
    PubMed         Abstract available


    Radiother Oncol

  85. RODRIGUEZ-LOPEZ JL, Ling DC, Keller A, Kim H, et al
    Ureteral Stenosis after 3D MRI-based Brachytherapy for Cervical Cancer - Have We Identified All the Risk Factors?
    Radiother Oncol. 2020 Oct 13. pii: S0167-8140(20)30846.
    PubMed         Abstract available

  86. SPAMPINATO S, Fokdal LU, Potter R, Haie-Meder C, et al
    Importance of the ICRU Bladder point dose on incidence and persistence of urinary frequency and incontinence in locally advanced cervical cancer: an EMBRACE analysis.
    Radiother Oncol. 2020 Oct 13. pii: S0167-8140(20)30839.
    PubMed         Abstract available


    Redox Biol

  87. PATINO-MORALES CC, Soto-Reyes E, Arechaga-Ocampo E, Ortiz-Sanchez E, et al
    Curcumin stabilizes p53 by interaction with NAD(P)H:quinone oxidoreductase 1 in tumor-derived cell lines.
    Redox Biol. 2020;28:101320.
    PubMed         Abstract available


    Reprod Sci

  88. DU P, Zhi Y, Wang R, Li Y, et al
    Aberrant Methylation of the SOX21-AS1 Promoter Region Promotes Gene Expression and Its Clinical Value in Cervical Cancer.
    Reprod Sci. 2020 Oct 23. pii: 10.1007/s43032-020-00335.
    PubMed         Abstract available


    Rev Invest Clin

  89. MANZO-MERINO J, Del-Toro-Arreola S, Rocha-Zavaleta L, Peralta-Zaragoza O, et al
    IMMUNOLOGY OF CERVICAL CANCER.
    Rev Invest Clin. 2020;72:188-197.
    PubMed         Abstract available

  90. JIMENEZ-LIMA R, Arango-Bravo E, Galicia-Carmona T, Lino-Silva LS, et al
    IMMUNOTHERAPY TREATMENT AGAINST CERVICAL CANCER.
    Rev Invest Clin. 2020;72:231-238.
    PubMed         Abstract available

  91. MEDINA-CONTRERAS O, Luvian-Morales J, Valdez-Palomares F, Flores-Cisneros L, et al
    IMMUNONUTRITION IN CERVICAL CANCER: IMMUNE RESPONSE MODULATION BY DIET.
    Rev Invest Clin. 2020;72:219-230.
    PubMed         Abstract available

  92. ENRIQUEZ-ACEVES I, Galicia-Carmona T, Coronel-Martinez JA, Espinosa-Romero R, et al
    STANDARD TREATMENT WITH BEVACIZUMAB AS TARGETED THERAPY IN CERVICAL CANCER.
    Rev Invest Clin. 2020;72:213-218.
    PubMed         Abstract available

  93. MALDONADO-CASTELLANOS I, Mora-Magana I
    CONSENSUS REPORT ON THE PREVENTION, DIAGNOSIS, AND TREATMENT OF CERVICAL CANCER - A PERSPECTIVE FROM THE IMMUNE SYSTEM TOWARD IMMUNOTHERAPY.
    Rev Invest Clin. 2020;72:259.
    PubMed        

  94. CETINA-PEREZ L, Castro-Eguiluz D
    CONSENSUS REPORT ON THE PREVENTION, DIAGNOSIS, AND TREATMENT OF CERVICAL CANCER - A PERSPECTIVE FROM THE IMMUNE SYSTEM TOWARD IMMUNOTHERAPY.
    Rev Invest Clin. 2020;72:185-187.
    PubMed        


    Trials

  95. MONTEALEGRE JR, Anderson ML, Hilsenbeck SG, Chiao EY, et al
    Mailed self-sample HPV testing kits to improve cervical cancer screening in a safety net health system: protocol for a hybrid effectiveness-implementation randomized controlled trial.
    Trials. 2020;21:872.
    PubMed         Abstract available


    Vaccines (Basel)

  96. LUVERO D, Lopez S, Bogani G, Raspagliesi F, et al
    From the Infection to the Immunotherapy in Cervical Cancer: Can We Stop the Natural Course of the Disease?
    Vaccines (Basel). 2020;8.
    PubMed         Abstract available


    Zhong Nan Da Xue Xue Bao Yi Xue Ban

  97. WANG C, Zhang K
    Advances in preservation of endocrine function with ovarian tissue cryopreservation and transplantation in cervical cancer.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020;45:994-998.
    PubMed         Abstract available


    Zhonghua Yi Xue Za Zhi

  98. XIA CF, Qiao YL, Zhang Y, Zhao FH, et al
    [WHO's global strategy of cervical cancer elimination and the challenges and initiatives in China].
    Zhonghua Yi Xue Za Zhi. 2020;100:E029.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: